Quick Answer
LISATA THERAPEUTICS, INC. reported Cash And Cash Equivalents At Carrying Value of $15.96 million for the year ending 2025.
- LISATA THERAPEUTICS, INC. showed a decrease of -1.6% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from LISATA THERAPEUTICS, INC.'s annual report (Form 10-K), filed with the SEC on March 12, 2026.
- XBRL data for this metric is available from 2009 to 2025 (18 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 18 years of available data (2009 to 2025), LISATA THERAPEUTICS, INC.'s Cash And Cash Equivalents At Carrying Value has grown by 122.9%.
- Historical annual values: Fiscal year 2025: $15.96 million | Fiscal year 2024: $16.21 million | Fiscal year 2023: $22.59 million | Fiscal year 2022: $32.15 million | Fiscal year 2021: $24.65 million | Fiscal year 2020: $16.51 million | Fiscal year 2019: $14.03 million | Fiscal year 2018: $10.30 million | Fiscal year 2017: $29.16 million | Fiscal year 2016: $7.08 million | Fiscal year 2015: $20.32 million | Fiscal year 2014: $19.17 million | Fiscal year 2013: $46.13 million | Fiscal year 2012: $13.74 million | Fiscal year 2012: $12.30 million | Fiscal year 2011: $3.94 million | Fiscal year 2010: $15.61 million | Fiscal year 2009: $7.16 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: